Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | NVP-BHG712 |
| Synonyms | |
| Therapy Description |
NVP-BHG712 is a small kinase inhibitor of EphB4, which has been shown to indirectly inhibit VEGF signaling thereby repressing angiogenesis (PMID: 20803239, PMID: 32336043). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| NVP-BHG712 | EPHB4 Inhibitor 6 | NVP-BHG712 is a small kinase inhibitor of EphB4, which has been shown to indirectly inhibit VEGF signaling thereby repressing angiogenesis (PMID: 20803239, PMID: 32336043). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|